COVID-19 behavior in Matanzas at 100 days of pandemic in Cuba
Keywords:
Key words, novel coronavirus, COVID, SARS-CoV-2Abstract
Introduction: the pandemic changed the world and also behavior in the province of Matanzas at 100 days from the first case in Cuba.
Objective: to characterize socio-demographic and clinical-epidemiological factors of the 207 COVID-19-confirmed patients in the province of Matanzas.
Materials and methods: this is a longitudinal, descriptive research where the behavior of the 207 COVID-19-positive patients found in the province of Matanzas was studied. Data were collected beginning from March 11, 2020, when the first cases ocurred in Cuba and until June 18, 2020, when it turned 100 days with the presence of cases infected with COVID-19. The authors analyzed socio-demographic factors, such as age, sex, living place, and clinical-epidemiological factors such as positive-patients comorbidities and infection source.
Results: active cases predominated in the municipalities of Matanzas and Cardenas, with predominace of females and 40-59 years ages; the most frequent infection form was the internal one; recovered patients predominated, and as death causes prevailed several comorbidities such as arterial hypertension and diabetes mellitus.
Conclusions: during the first 100 days of epidemic in Cuba, the behavior varied in the province due to the local transmission events opened in the territory.
Downloads
References
2. Pérez Abreu MR, Gómez Tejeda JJ, Diéguez Guach RA. Características clínico-epidemiológicas de la COVID-19. Rev Haban Cienc Méd [Internet]. 2020 [citado 04/05/2020]; 19(2). Disponible en: http://www.revhabanera.sld.cu/index.php/rhab/article/view/3254/2505.
3. Herrera F. Nuevo coronavirus SARS-COV-2 y enfermedad COVID-19. La pandemia que cambió al mundo. Rev Hematología [Internet]. 2020 [citado 04/05/ 2020]; 24(no. ext.). Disponible en: http://revistahematologia.com.ar/index.php/Revista/article/view/271.
4. Durán García F. Conferencia de prensa del MINSAP sobre la COVID-19. Sitio Oficial de Gobierno [Internet]. La Habana: Ministerio de Salud Pública en Cuba; 2020 [citado 19/06/ 2020]. Disponible en: https://salud.msp.gob.cu/.
5. Cuba. Centro Nacional de Información de Ciencias Médicas. Infecciones por coronavirus. Temas de salud [Internet]. La Habana: Centro Nacional de Información de Ciencias Médicas; 2020 [citado 15/06/2020]. Disponible en: https://temas.sld.cu/coronavirus/2020/06/15/nota-informativa-sobre-la-covid-19-en-cuba-14-de-junio/.
6. MINSAP. Información para Directivos de la Salud. Infodir [Internet]. 2020 [citado 24/06/2020]; 32: e831. Disponible en: http://revinfoder.sld.cu/index.php/.
7. Leyva Caballero R. Voluntad política e intersectorialidad para el enfrentamiento a la COVID-19 en Cuba. Rev Haban Cienc Méd [Internet]. 2020 [citado 04/05/2020]; 19(2). Disponible en: http://www.revhabanera.sld.cu/index.php/rhab/article/view/3241/2507.
8. Gobierno Provincial Matanzas. Actualización del COVID-19 en Matanzas [Internet]. Matanzas: Gobierno Provincial de Matanzas; 2020 [citado 19/06/2020]. Disponible en: www.matanceros.gob.cu.
9. Medina Mendieta JF, Cortés Cortés ME, Cortés Iglesias M. Ajuste de curvas de crecimiento poblacional aplicadas a la COVID-19 en Cuba. Rev Haban Cienc Méd [Internet]. 2020 [citado 21/06/2020]; 19(Supl.): e3353. Disponible en: http://www.revhabanera.sld.cu/index.php/rhab/article/view/3353.
10. Portal Miranda JA. Etapa pos-COVID-19 en Cuba: prioridades y medidas del sistema nacional de salud. Infodir [Internet]. 2020 [citado 24/06/ 2020]; 32. Disponible en: http://revinfoder.sld.cu/index.php/.
11. Ferrer Castro JE, Sánchez Hernández E, Poulout Mendoza A, et al. Caracterización clínica y epidemiológica de pacientes confirmados con la COVID-19 en la provincia de Santiago de Cuba. Medisan [Internet]. 2020 [citado 29/06/2020]; 24(3). Disponible en: http://medisan.sld.cu/idex.php/.
12. Dong Y, Mo X, Hu Y, et al. Epidemiology of COVID-19 among children in China. Pediatrics [Internet]. 2020 [citado 05/06/2020]; 145(6): e20200702. Disponible en: https://pediatrics.aappubiications.org/content/145/6/e20200702.
13. CDC COVID-19 Response Team. Coronavirus disease in children – United States, February 12-April 2, 2020. Morb Mortal Wkly Rep [Internet]. 2020 [citado 05/06/2020]; 69(14): 422-6. Disponible en: https://www.researchgate.net/publication/340472494.
14. Builes Montaño CE, Ramírez Rincón A. Diabetes mellitus en COVID-19: ¿factor de riesgo o factor pronóstico? Rev Colomb Endocrinol [Internet]. 2020 [citado 25/06/2020]; 7(2 Supl.). Disponible en: http://revistaendocrino.org/index.php/rcedm/article/view/585.
15. Espinosa Brito A. COVID-19: rápida revisión general. Anales de la Academia de Ciencias de Cuba [Internet]. 2020 [citado 25/06/2020]; 10(2). Disponible en: http://revistaccuba.sld.cu/index.php/revacc/article/view/828/844.
16. López Sousa AF, Félix de Carvalho HE, Braz de Oliveira L, et al. Effects of COVID-19 infection during pregnancy and neonatal prognosis: what is the evidence. Int J Environ Res Public Health 2020; 17(11): 4176. Citado en PubMed; PMCID: PMC7313049.
17. Cobas Planchez L, Mezquia de PN, Armenteros Terán SS. Características clínicas de pacientes con sospecha de COVID-19 ingresados en el hospital “Frank País García”, La Habana. Rev Zoi Marin [Internet]. 2020 [citado 25/06/2020]; 45(4). Disponible en: http://revzoilomarinello.sld.cu/index.php.
18. Chen X, Hu W, Ling J, et al. Hypertension and Diabetes Delay the Viral Clearance in COVID-19 Patients. Med Rxiv [Internet]. 2020 [citado 24/04/2020]. Disponible en: https://www.medrxiv.org/content/10.1101/2020.03.22.20040774v1.full.pdf.
19. Giralt-Herrera A, Rojas-Velázquez JM, Leiva-Enríquez J. Relación entre COVID-19 e Hipertensión Arterial. Rev Haban Cienc Méd [Internet]. 2020 [citado 24/04/2020]; 19(2): e_3246. Disponible en: http://www.revhabanera.sld.cu/index.php/rhab/article/view/3246.
20. MINSAP. Fármacos cubanos muestran resultados promisorios frente a la COVID-19 [Internet]. La Habana: Infomed [citado 24/04/2020]; 2020 Disponible en: http://www.infomed.sld.cu/noticia/2020/05/22/farmacos-cubanos-muestran-resultados-promisorios-frente-la-covid-19.
Published
How to Cite
Issue
Section
License
All content published in this journal is Open Access, distributed under the terms of the CC BY-NC 4.0 License.
It allows:
- Copy and redistribute published material in any medium or format.
- Adapt the content.
This will be done under the following terms:
- Attribute the authors' credits and indicate whether changes were made, in which case it must be in a reasonable way.
- Non-commercial use.
- Recognize the journal where it is published.
The copyrights of each article are maintained, without restrictions.
Guidelines to authors
